biomedicina slovenica

pr=Arbyn : 37

Xu Lan; Padalko Elizaveta; Oštrbenk Valenčak Anja; Poljak Mario; Arbyn Marc
Clinical evaluation of INNO-LiPA HPV genotyping EXTRA II assay using the VALGENT framework
2022 ►
Arbyn Marc; Canfell Karen; Poljak Mario; Berkhof Johannes; de Sanjosé Silvia; Wentzensen Nicolas
HPV mRNA testing in cervical cancer screening
2022 ►
Arbyn Marc; Bonde Jesper; Cushieri Kate; Poljak Mario
Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?
2022 ►
Arbyn Marc; Gultekin Murat; Morice Philippe; Nieminen Pekka; Cruickshank Maggie; Poortmans Philip; Kelly Daniel; Poljak Mario; Bergeron Christine; Ritchie Glenn David
The European response to the WHO call to eliminate cervicalcancer as a public health problem
2021 ►
Arbyn Marc; Simon Marie; Peeters Eliana; Xu Lan; Meijer Chris J.L.M.; Berkhof Johannes; Cuschieri Kate S.; Bonde Jesper; Oštrbenk Valenčak Anja; Poljak Mario
2020 list of human papillomavirus assays suitable for primary cervical cancer screening
2021 ►
Ritchie Glenn David; Arbyn Marc; Basu Partha; Corbex Marilys; Fidarova Elena; Ivanuš Urška; Papi Ginevra; Torode Julie; Zacharopoulou Chrysoula
Europe's path to eliminating cervical cancer as a public health problem
2022 ►
Arbyn Marc; Bruni Laia; Basu Partha; Poljak Mario; Gultekin Murat; Bergeron Christine; Ritchie Glenn David; Weiderpass Elisabete
Tackling cervical cancer in Europe amidst the COVID-19 pandemic
2020 ►
Robles Claudia; Bruni L.; Poljak Mario; Lehtinen Matti; Dillner J.; Kjaer S.; Petry K. U.; Arbyn Marc; Cuzick Jack; Clavel Christine
HPV vaccine uptake and associated factors in adult women aged up to 45 years from 9 European countries (COHEAHR-WP4 study)
2020 ►
Kyrgiou Maria; Arbyn Marc; Bergeron Christine; Bosch Francesc Xavier; Dillner J.; Jit Mark; Poljak Mario; Nieminen Pekka; Sasieni Peter; Kesić Vesna
Cervical screening
2020 ►
Poljak Mario; Oštrbenk Valenčak Anja; Gimpelj Domjanič G.; Xu Lan; Arbyn Marc
Commercially available molecular tests for human papillomaviruses
2020 ►
Xu Lan; Benoy Ina; Cuschieri Kate S.; Poljak Mario; Bonde Jesper; Arbyn Marc
Accuracy of genotyping for HPV16 and 18 to triage women with low-grade squamous intraepithelial lesions
2019 ►
Oštrbenk Anja; Xu Lan; Arbyn Marc; Poljak Mario
Clinical and analytical evaluation of the anyplex II HPV HR detection assay within the VALGENT-3 framework
2018 ►
Viti Jessica; Poljak Mario; Oštrbenk Anja; Bhatia Ramya; Alcañiz Boada Elia; Cornall Alyssa M.; Cuschieri Kate S.; Garland Suzanne; Xu Lan; Arbyn Marc
Validation of EUROArray HPV test using the VALGENT framework
2018 ►
Fröberg Maria; Östensson Ellinor; Belkić Karen; Oštrbenk Anja; Poljak Mario; Mints Miriam; Arbyn Marc; Andersson Sonia
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline
2018 ►
Oštrbenk Anja; Seme Katja; Xu L.; Arbyn Marc; Poljak Mario
HPV type - specific agreement between linear array HPV genotyping test, Anyplex II HPV28 and 21 HPV genoarray within the VALGENT-3 framework
2018 ►
Xu Lan; Padalko E.; Oštrbenk Anja; Poljak Mario; Arbyn Marc
Clinical evaluation of INNO - LiPA HPV Genotyping EXTRA II assay using the VALGENT framework
2018 ►
Oštrbenk Anja; Germ Julija; Seme Katja; Xu Lan; Arbyn Marc; Poljak Mario
Comparison of the abbott realtime high risk HPV, the COBAS 4800 HPV and the Hybrid Capture 2 within the VALGENT-3 framework
2018 ►
Benoy Ina; Xu Lan; Vanden Broeck D.; Poljak Mario; Oštrbenk Anja; Arbyn Marc; Bogers Johannes
Calculation of a viral cut - off allows flexibility to optimize the clinical accuracy required for HPV assays in primary cervical cancer screening
2018 ►
Oštrbenk Anja; Seme Katja; Xu Lan; Arbyn Marc; Poljak Mario
Comparison of the Hybribio's 21 HPV genoarray diagnostic test and Hybrid Capture 2 in the VALGENT-3 framework
2018 ►
Oštrbenk Anja; Seme Katja; Xu Lan; Arbyn Marc; Poljak Mario
HPV type - specific agreement between linear array HPV genotyping test, ANYPLEX II HPV28 and 21 HPV genoarray within the VALGENT-3 framework
2018 ►
Cornall A. M.; Viti J.; Poljak Mario; Oštrbenk Anja; Bhatia R.; Alca niz Boada E.; Cuschieri Kate S.; Garland S.; Xu Lan; Arbyn Marc
Validation of EUROarray HPV test using the VALGENT framework
2018 ►
Polman N. J.; Oštrbenk Anja; Xu Lan; Snijders Peter .J.F.; Poljak Mario; Heideman D. A. M.; Arbyn Marc
Evaluation of the clinical performance of the HPV-risk assay using the VALGENT-3 panel
2017 ►
Xu Lan; Oštrbenk Anja; Poljak Mario; Arbyn Marc
Assessment of the Roche linear array HPV genotyping test within the VALGENT framework
2018 ►
Benoy Ina; Vanden Broeck D.; Bogers Johannes; Oštrbenk Anja; Poljak Mario; Arbyn Marc
Optimization of the Riatol qPCR HPV genotyping assay by choosing a threshold assuring satisfactory accuracy to detect high grade cervical intraepithelial neoplasia
2017 ►
Poljak Mario; Rogovskaya Svetlana; Seme Katja; Maver Vodičar Polona; Kocjan Boštjan; Cuschieri Kate S.; Arbyn Marc; Syrjänen Stina
Cervical cancer & cytology based screening programs in Eastern and Central European countries
2012 ►
Oštrbenk Anja; Seme Katja; Arbyn Marc; Poljak Mario
Head - to - head comparison of the Anyplex II HPV HR detection and the Hybrid Capture 2 in the Valgent - 3 framework
2017 ►
Xu L.; Oštrbenk Anja; Poljak Mario; Arbyn Marc
Assessment of Roche linear array hpv genotyping test using the VALGENT framework
2017 ►
Bosch Francesc Xavier; Robles Claudia; Díaz Mireia; Arbyn Marc; Baussano Iacopo; Clavel Christine; Ronco Guglielmo; Dillner J.; Lehtinen Matti; Poljak Mario
HPV-FASTER
2016 ►
Arbyn Marc; Depuydt Christophe; Benoy Ina; Bogers Johannes; Cuschieri Kate S.; Schmitt Markus; Pawlita Michael; Geraets Daan; Heard Isabelle; Poljak Mario
VALGENT
2016 ►
Rossi Paolo Giorgi; Ronco Guglielmo; Dillner J.; Elfström K. Miriam; Snijders Peter .J.F.; Arbyn Marc; Berkhof Johannes; Carozzi Francesca; Del Mistro Annarosa; Poljak Mario
Why follow-back studies should be interpreted cautiously
2016 ►
Arbyn Marc; Snijders P.J.F.; Meijer C. J. L. M.; Berkhof Johannes; Cuschieri Kate S.; Kocjan Boštjan; Poljak Mario
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
2015 ►
Poljak Mario; Rogovskaya Svetlana; Kesić Vesna; Bray Freddie; Berkhof Johannes; Seme Katja; Brotons Maria; Castellsagué Xavier; Syrjänen Stina; Arbyn Marc; Bosch Francesc Xavier
Recommendations for cervical cancer prevention in Central and Eastern Europe and Central Asia
2013 ►
Poljak Mario; Seme Katja; Maver Vodičar Polona; Kocjan Boštjan; Cuschieri Kate S.; Rogovskaya Svetlana; Arbyn Marc; Syrjänen Stina
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe
2013 ►
Bray Freddie; Lortet-Tieulent Joannie; Znaor Ariana; Brotons Maria; Poljak Mario; Arbyn Marc
Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia
2013 ►
Arbyn Marc; Ronco Guglielmo; Anttila Ahti; Meijer Chris JLM; Poljak Mario; Ogilvie Gina; Koliopoulos George; Naucler Pontus; Sankaranarayanan Rengaswamy; Peto Julian
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer
2012 ►
Poljak Mario; Cuzick Jack; Kocjan Boštjan J; Iftner Thomas; Dillner Joakim; Arbyn Marc
Nucleic acid tests for the detection of alpha human papillomaviruses
2012 ►
Arbyn Marc; Primic-Žakelj Maja; Raifu Amidu O; Grce Magdalena; Paraskevaidis Evangelos; Diakomanolis Emanuel; Kesić Vesna; Nicula Florian A.; Suteu Ofelia; Karsa Lawrence von
The burden of cervical cancer in south-east Europe at the beginning of the 21st century
2007 ►

New search Comments Top of page Institute for Biostatistics and Medical Informatics